Targeted therapies for cervical cancer

Targeted therapies interfere with the messages cancer cells need to grow and divide.

Bevacizumab (Avastin®) is a targeted treatment which has been used to treat other types of cancer. Research has shown that it might be a useful treatment alongside chemotherapy for women with advanced cervical cancer.

It may not be widely available. In England, if your specialist thinks bevacizumab is suitable for you, they can apply for you to have it through the Cancer Drugs Fund. If you live in Scotland, Wales or Northern Ireland you can find out from your specialist if bevacizumab is available.

Back to Targeted (biological) therapies explained

Monoclonal antibodies

Monoclonal antibodies can attach themselves to cancer cells to prevent them from growing.